Real-World Implementation of a Genotype-Guided P2Y 12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients. JACC Cardiovasc Interv 2024;17:1996-2007. Use of a genotype-guided ...

The following are key points to remember from a European Society of Cardiology (ESC) clinical consensus statement on obesity and cardiovascular disease (CVD): ...

In this special edition of Eagle’s Eye View, Dr. Eagle summarizes the most important trials that were featured at the ESC Congress 2024, August 30 to September 2—eight trials that could have ...

Valgimigli M, Hong SJ, Gragnano F, et al., on behalf of the Single Versus Dual Antiplatelet Therapy (Sidney-4) Collaborator Group. The current analysis was an in-depth review of existing literature of ...

The event rates of standardized composite kidney endpoints in clinical studies were largely influenced by different eGFR thresholds used to define a sustained and meaningful decline in kidney function ...

It is imperative that clinicians understand the differences in each patient and how effective therapies must be individualized and often combined to treat patients with varying profiles. Efforts to ...

In this week’s View, Dr. Eagle looks at temporary mechanical circulatory support in infarct-related cardiogenic shock. He then explores the anticoagulation benefit in device-detected atrial ...

“PulseCheck” is a series within CardiaCast that is designed for nurses or allied healthcare professionals who are new, or new to cardiology, offering practical team-based solutions to the challenges ...

Among subjects who underwent T-TEER for at least moderate tricuspid regurgitation (TR) in the TRILUMINATE study, there was a sustained decrease in TR severity and 79% of subjects had no more than ...

The MOST trial failed to show that adjuvant argatroban or eptifibatide reduced disability when added to intravenous thrombolytic therapy for acute ischemic stroke. Patients with acute ischemic stroke ...

Not only do former smokers have lower risk of atrial fibrillation (AFib) than current smokers, but patients who quit smoking may reduce their AFib risk while doing so, according to a longitudinal ...

Early routine use of mechanical circulatory support (MCS) in patients with infarct-related cardiogenic shock (in addition to revascularization) does not improve 6-month all-cause mortality. Patients ...